Emily Butler
About Emily Butler
Emily Butler SVP Biometrics
Emily Butler holds the position of Senior Vice President (SVP) of Biometrics. In this role, she oversees the development and implementation of statistical methodologies to support clinical trials and regulatory submissions. Her extensive background in biostatistics helps drive the strategic direction of her department, ensuring the delivery of robust and reliable data analyses.
Emily Butler Education and Expertise
Emily Butler earned her PhD in Biostatistics from the University of North Carolina at Chapel Hill, where she developed a deep understanding of statistical theory and its application to medical research. She also holds a BS in Statistics from Carnegie Mellon University, which provided her foundational knowledge in statistical principles. Her academic credentials bolster her expertise in biostatistics, translating complex data into actionable insights in the field of biometrics.
Emily Butler GlaxoSmithKline Experience
Before her current role, Emily Butler worked at GlaxoSmithKline (GSK), where she supported the oncology therapeutic area. During her time at GSK, she was involved in significant projects that aimed to advance cancer treatment through rigorous data analysis and biostatistical support. Her contributions helped shape the development and evaluation of new oncology therapies.
Emily Butler Cell Therapy Development
Emily Butler has led the early phase development of cell therapy assets targeting both solid tumors and hematological malignancies. Her leadership in these early stages is pivotal to the innovative approaches in treating various forms of cancer. This role involves coordinating between research teams, managing data collection and analysis, and ensuring adherence to regulatory standards to pave the way for subsequent clinical trial phases.